Results 151 to 160 of about 28,984 (253)
This study provides new data for the stability constants of lanthanide complexes using spectrometric methods with different approaches, considering the stability differences. Clinical applications ranging from magnetic resonance imaging to cancer therapy are more relying on the use of lanthanide coordination compounds.
Wanqi Zhou +5 more
wiley +1 more source
Carbon Ion Radiotherapy for Prostate Cancer
Purpose: Analysis of the results of hypofractionated conformal carbon ion radiotherapy (C-ion RT) for localized prostate cancer was performed, with regard to normal tissue morbidity, biochemical relapse-free rate (bNED), and patient survival. Methods and Materials: Five hundreds and forty-two prostate cancer patients who received C-ion RT established ...
+5 more sources
Novel Physical and Biological Applications of Carbon Ion Radiotherapy. [PDF]
Seneviratne D, Biswal P, Krishnan S.
europepmc +1 more source
Curcumin Nanoformulations for Dermatological Applications: From Nutraceuticals to Nanocarriers
Nanotechnology‐based delivery platforms enhance the cutaneous administration of curcumin. Loading free curcumin into polymeric micelles, metal‐based nanoparticles, nanogels/hydrogels, liposomes, polymeric nanoparticles, or nanoemulsions/nanocrystals helps address its low solubility, poor stability and limited skin permeation. As a result, these systems
Stephany Celeste Gutiérrez‐Ruiz +13 more
wiley +1 more source
Out-of-beam artifact suppression in charged nuclear fragment based carbon-ion radiotherapy monitoring. [PDF]
Kirchgässner R +7 more
europepmc +1 more source
Resveratrol for Cancer Radio‐Sensitization: Ready for Prime Time or Future Perspective
Resveratrol exerts antioxidant and anti‐inflammatory effects by reducing reactive oxygen species and suppressing NF‐κB and JAK/STAT signaling pathways. It modulates metabolic signaling through AMPK‐dependent inhibition of mTOR, influencing cell survival and inflammatory responses.
Maryam Fallah +7 more
wiley +1 more source
Carbon ion radiotherapy at NIRS
In 1994, carbon ion radiotherapy was begun at the National Institute of Radiological Sciences using the Heavy Ion Medical Accelerator in Chiba, which was the worlds rst heavy ion accelerator complex dedicated to medical use in a hospital environment. Among several types of ion species, carbon ions were selected for cancer therapy because they
openaire
Reconstruction techniques in nuclear medicine time-of-flight PET [PDF]
Vandenberghe, Stefaan
core +1 more source
ABSTRACT Objective To evaluate clinical outcomes and quality of life (QOL) following hypofractionated spot‐scanning proton therapy (SSPT) for head and neck malignant mucosal melanoma (HNMM). Methods This retrospective study included 39 patients treated with SSPT (60–64 Gy[RBE] in 15–16 fractions) between 2013 and 2023.
Koichiro Nakajima +11 more
wiley +1 more source

